Inventor

SPIEGELMAN BRUCE M

US39 patents

⚠️ This page may combine multiple inventors who share the name “SPIEGELMAN BRUCE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPIEGELMAN BRUCE M

DANA FARBER CANCER INST INC

Methods and pharmaceutical compositions for inhibiting tumor cell growth

Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function

Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function

PGC-1β, a novel PGC-1 homologue and uses therefor

PGC-1β, a novel PGC-1 homologue and uses therefor

PGC-1, a novel brown fat PPARγ coactivator

PCG-1, a novel brown fat PPARγ coactivator

Methods and pharmaceutical compositions for inhibiting tumor cell growth

Angiogenic monoglycerides

Methods and compositions for treating obesity

PGC-1 isoforms and uses therefor

Compositions and methods for regulating pancreatic beta cell function using adipsin

Compositions and methods for regulating pancreatic beta cell function using adipsin

PGC-1, a novel brown fat PPARγ coactivator

PGC-1, a novel brown fat PPARgamma coactivator

PGC-1, a novel brown fat pparγ coactivator

Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids

Compositions and methods for brown fat induction and activity using FNDC5

Compositions and methods for induced brown fat differentiation

Methods for the treatment of neurological disorders and diseases using FNDC5

Methods for the treatment of neurological disorders and diseases using FNDC5

Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2

Compositions and methods for modulating PGC-1α to treat huntington&#39;s disease

Chemical uncouplers of respiration and methods of use thereof

Methods and pharmaceutical compositions for inhibiting tumor cell growth

Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn

Methods and compositions for modulating gluconeogenesis using PGC-1

SPIEGELMAN BRUCE M

Compositions and methods for brown fat induction and activity using FNDC5

Compositions and methods for brown fat induction and activity using FNDC5

Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders

PGC-1β, a novel PGC-1 homologue and uses therefor

PGC-1β, PGC-1 homologue and uses therefor

Compositions and methods for induced brown fat differentiation

Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders

BETH ISRAEL HOSPITAL

DNA encoding human adipsin with complement D activity

JOSLIN DIABETES CENTER INC

Method for effecting vasodilation with monoglycerides

(unassigned)

Adipocyte-specific DNA sequences and use thereof in the production of transgenic animals exhibiting altered fat tissue metabolism

SALK INST FOR BIOLOGICAL STUDI

Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter

SEALE PATRICK

Molecular control of brown fat differentiation and energy expenditure

Compositions and methods for modulating PGC-1α to treat huntington's disease